Date of Publication
2009
Document Type
Master's Thesis
Degree Name
Master of Business Administration
Subject Categories
Intellectual Property Law
College
Ramon V. Del Rosario College of Business
Department/Unit
Business Management
Thesis Adviser
Sammuel Z. Lee
Defense Panel Chair
Antonio Concepcion
Defense Panel Member
Andres San Mateo
Krisanto Karlo Nicolas
Abstract/Summary
The proliferation of fake drugs, especially those contaminated with toxic chemicals, is becoming a huge threat to the health of the Filipinos and to the trade and manufacturing industry of the pharmaceutical sector directly affecting its industry credibility, undermining its business stability. By addressing this problem, this paper seeks to determine how the government can manage the spread of counterfeit drugs in the Philippine market. Various policies are provided with the hope that it will call on the attention of the legislature to conduct an inquiry, in aid of legislation, for amendments of existing laws or enactment of new laws. These will evaluate the possible legal remedies and will look at the best way to deal with the proliferation of fake drugs. In addition, it considers the conflict that arises when government agencies aim to reduce the harmful effects of the fake medicine trade while the pharmaceutical firms seek profit maximization. Thus, in order to protect the right of the people to good health, there is a need to re-assess the rules and regulations of the Bureau of Food and Drugs (BFAD) as well as their manner of enforcement of laws to develop policy options addressed to the legislative body of the Philippine government.
Abstract Format
html
Language
English
Format
Electronic
Accession Number
CDTG004416
Shelf Location
Archives, The Learning Commons, 12F, Henry Sy Sr. Hall
Physical Description
115 leaves
Keywords
Product counterfeiting—Philippines; Product counterfeiting—Law and legislation—Philippines; Pharmaceutical industry—Corrupt practices—Philippines
Upload Full Text
wf_yes
Recommended Citation
Amoranto, S. S. (2009). Policy options in preventing drug counterfeiting activities in the Philippines. Retrieved from https://animorepository.dlsu.edu.ph/etd_masteral/6663
Embargo Period
4-1-2022